Infectious diseases ; high-security animal care facilities ; immunology ; physiopathology

Equipements plateforme animalerie infectieuse de haute-sécurité de Midi Pyrénées

Equipements d'excellence (EQPX)

Equipements d'excellence

Informations générales

Référence projet : 11-EQPX-0003
Etablissement Coordinateur : INSERM Toulouse
Région du projet : Occitanie
Discipline : 5 - Bio Med

Aide de l'ANR 2 501 800 euros
Investissement couvrant la période de octobre 2012 à décembre 2019

Résumé de soumission

Infectious diseases are still responsible for nearly 25% of the total worldwide human mortality, with a global annual toll of about 13 million human lives. Research on pathogenic microorganisms brought huge progress and revealed essential clues for infection control programs. However, there is still a crucial need of better vaccines and new antimicrobials. The Aninfimip is an EquipEx (‘Equipement d’Excellence’) supported by the French government allowing the development of high-standard, high-security animal facilities with integrated and mutualized state-of-the-art equipment for monitoring physiological parameters and functional exploration of the immune response in the context of infectious diseases. A special emphasis is put on medical imaging systems that make possible functional monitoring of infected animals. Aninfimip allows the integrated mutualisation of infrastructure and equipment, open to the public and private sectors involved in infectiology and drug/vaccine development. The Aninfimip project gathers together major partners in academic research in infectious diseases in Toulouse. During the first period of the project, the two million euro of investment was used to equip three different high-security animal care facilities in Toulouse. All the pieces of equipment are now functional in the three different sites and are integrated in the framework of the regional scientific platforms. International competitiveness of research conducted in Toulouse on infectious diseases and immunology in the academic and private sectors is undoubtedly fostered by the Aninfimip project, which is a key asset for the development of new options for the diagnosis, prevention and treatment of infection.

L'auteur de ce résumé est le coordinateur du projet, qui est responsable du contenu de ce résumé. L'ANR décline par conséquent toute responsabilité quant à son contenu.

Liens utiles